Spike RBD Antibody (1035240) [PE]
Novus Biologicals, part of Bio-Techne | Catalog # FAB105406P

Conjugate
Catalog #
Key Product Details
Species Reactivity
SARS-CoV-2
Applications
Blockade of Receptor-ligand Interaction, ELISA
Label
PE (Excitation = 488 nm, Emission = 575 nm)
Antibody Source
Monoclonal Mouse IgG2A Clone # 1035240
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
HEK293 Human embryonic kidney cell -derived SARS-CoV-2 Spike S1
Met1-Tyr674
Accession # YP_009724390.1
Met1-Tyr674
Accession # YP_009724390.1
Specificity
In a functional flow cytometry assay, this antibody binds and blocks SARS-CoV-2 Spike RBD interaction with human ACE-2 transfectants. Detects SARS-CoV-2 Spike RBD in sandwich ELISAs.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2A
Applications for Spike RBD Antibody (1035240) [PE]
Application
Recommended Usage
Blockade of Receptor-ligand Interaction
Optimal dilutions of this antibody should be experimentally determined.
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from hybridoma culture supernatant
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Spike RBD
Long Name
Spike Receptor Binding Domain
Additional Spike RBD Products
Product Documents for Spike RBD Antibody (1035240) [PE]
Product Specific Notices for Spike RBD Antibody (1035240) [PE]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...